Professor Kamlesh Khunti is a pioneer in type 2 diabetes research and is ranked third among the top 10 of the world’s leading experts into the condition. A co-founder of the Leicester Diabetes ...
Using a FreeStyle Libre halves the risk of being admitted to hospital with diabetic ketoacidosis (DKA), according to researchers. More than 74,000 people took part in the RELIEF study, of which ...
Newly published research has shown the FreeStyle Libre reduces HbA1c levels for people with type 2 diabetes on either long-acting insulin or non-insulin therapy. Abbott, the company that makes ...
A leading type 2 diabetes professor has developed a Risk Reduction Framework for NHS staff who may be at risk of COVID-19. Professor Kamlesh Khunti, Professor of Primary Care Diabetes and ...
Guidelines to support Muslim people with type 2 diabetes who wish to fast during Ramadan have been published. Although the Qur’an states that illness constitutes an exemption from fasting during ...
Keeping good blood glucose management could help improve the prognosis of people with COVID-19 and pre-existing diabetes, according to researchers. This study also further supports previous ...
The SGLT2 inhibitor dapagliflozin is being tested to see if it can help reduce COVID-19 progression, complications and death among adults with cardiovascular, metabolic or renal risk factors. ...
A Metabolic Medicine professor based in Scotland has been awarded the prestigious Camillo Golgi Prize by the European Association for the Study of Diabetes (EASD). Professor Naveed Sattar, from ...
New strategies to lower cardiovascular risk, heart failure hospitalisation and mortality in type 2 diabetes will be discussed at forthcoming diabetes event. Kidneys, Heart and Diabetes: Science ...
Dental teams could play an integral role in identifying people at high risk of developing type 2 diabetes, according to new research. The systematic review, led by researchers in the University ...